Showing results (191-200 of 388) with videos related to
Sort By:
Pageof 39
Molecular Cancer Therapeutics|April 14, 2007
Novel xenograft model expressing human hepatocyte growth factor shows ligand-dependent growth of c-Met-expressing tumorsTodd D Francone, Ron G Landmann, Chin-Tung Chen, et al.Cancer Immunology Research|March 2, 2021
Oncogenic KIT Modulates Type I IFN-Mediated Antitumor Immunity in GISTMengyuan Liu, Mark S Etherington, Andrew Hanna, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Gene expression in gastrointestinal stromal tumors is distinguished by KIT genotype and anatomic siteCristina R Antonescu, Agnes Viale, Lisa Sarran, et al.Annals of Surgical Oncology|June 24, 2011
Is port site resection necessary in the surgical management of gallbladder cancer?Ajay V Maker, Jean M Butte, Jacqueline Oxenberg, et al.Annals of Surgery|September 16, 2008
A prospective randomized trial of acute normovolemic hemodilution compared to standard intraoperative management in patients undergoing major hepatic resectionWilliam R Jarnagin, Mithat Gonen, Shishir K Maithel, et al.Annals of Surgery|April 26, 2005
Papillary phenotype confers improved survival after resection of hilar cholangiocarcinomaWilliam R Jarnagin, Wilbur Bowne, David S Klimstra, et al.Annals of Surgery|January 12, 2024
Randomized Prospective Trial of Epidural Analgesia after Open HepatectomyVittoria Arslan-Carlon, Motaz Qadan, Vinay Puttanniah, et al.Oncogene|July 19, 2023
Multiple intratumoral sources of kit ligand promote gastrointestinal stromal tumorAndrew D Tieniber, Ferdinando Rossi, Andrew N Hanna, et al.Cancer|February 23, 2007
Management of primary liver sarcomasJuürgen Weitz, David S Klimstra, Karina Cymes, et al.Journal of the American College of Surgeons|July 25, 2015
Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic ModelsAlexandre Doussot, Bas Groot-Koerkamp, Jimme K Wiggers, et al.Pageof 39